CARL ZEISS MEDITEC AG

Zeiss Meditec’s stock gains 1.36% to €35.54 as its AI‑powered ophthalmic tech and global reach drive a 15.92% rally, making it a top tech‑health pick.

Zeiss Meditec stock climbs 1.36% as its tech‑driven ophthalmic solutions keep investors bullish—see why 2026 growth prospects remain strong.

Zeiss Meditec shares climb 3% amid strong 52‑week high, 200‑day MA support and a bullish outlook driven by new ophthalmic launches and expanding markets.